News Release

<< Back

SurModics to Host Investor Day on November 15th in New York City

Webcast is Live at 8:30 a.m. (ET)

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Nov. 7, 2007--SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and drug delivery technologies to the healthcare industry, announced today that it will host an Investor Day beginning at 8:30 a.m. ET on November 15th at the NASDAQ MarketSite in New York City.

Bruce Barclay, President and Chief Executive Officer, Phil Ankeny, Senior Vice President and Chief Financial Officer, and business unit general managers will deliver presentations reviewing SurModics' businesses and strategy in addition to outlining the fiscal year 2008 corporate goals. Management will also host question and answer sessions with investors.

The Investor Day will be webcast live over the Internet in listen-only mode. Participants can link to the webcast by going to the investor relations portion of the company's web site, www.surmodics.com, on the day of event and clicking on the webcast icon. The webcast will be available for replay on the SurModics website shortly after the event concludes.

About SurModics, Inc.

SurModics, Inc. is a leading provider of surface modification and drug delivery technologies to the healthcare industry. SurModics partners with the world's foremost medical device, pharmaceutical and life science companies to develop and commercialize innovative products that result in better patient outcomes. Core offerings include: drug delivery technologies (coatings, microparticles, and implants); surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities; and components for in vitro diagnostic test kits and specialized surfaces for cell culture and microarrays. Collaborative efforts include a sustained drug delivery system in human trials for treatment of retinal disease and the drug delivery polymer matrix on the first-to-market drug-eluting coronary stent. SurModics is headquartered in Eden Prairie, Minnesota and its Brookwood Pharmaceuticals subsidiary is located in Birmingham, Alabama. For more information about the company, visit www.surmodics.com. The content of SurModics' web site is not part of this release or part of any filings the company makes with the SEC.

CONTACT: SurModics, Inc.
Phil Ankeny
Senior Vice President and Chief Financial Officer
(952) 829-2700

SOURCE: SurModics, Inc.